ASGCT 28th Annual Meeting

May 13-17, 2025 

New Orleans, LA  

Visit us at BOOTH #1610

Request a meeting on-site with our team to discuss your project and how we can help you advance your therapeutic drug development program.

ASGCT logo_white

Presentation by BioAgilytix

SPONSORED SYMPOSIA
Overcoming Challenges for Advanced Therapeutics:
Case Studies on Navigating the Unique Bioanalytical and CMC Characterization Landscape of Cell and Gene Therapies 
Presenters:  
 - Lynn Kamen, PhD, Scientific Officer 
 - Jessica Weaver, PhD, Scientific Officer
 
Wednesday, May 14, 12:15-1:15 PM 
Location: Room 383-385 
lynn-Kamen
Jessica-Weaver

Customized approaches to support your bioanalytical needs

With over a decade of gene and cell therapy experience, we have worked with over a hundred partners to build the right bioanalytical package based on the current regulatory standards, from GMP, GLP, GCP, to CLIA and IDE/IVDR.  

We provide the complete package of pharmacokinetic (PK), immunogenicity, biomarker, and CMC analytical testing services. Our labs provide immunoassay, cell-based assay, molecular biology, and LC/MS assay development, validation, and sample testing, which eliminates the need for multiple providers, ensuring efficient delivery of data for your therapeutic study.  

We operate state-of-the-art laboratories in Durham, North Carolina; Boston, Massachusetts; San Diego, California; Melbourne and Brisbane, Australia; and Hamburg, Germany.  

Schedule a meeting with our experts on site

Learn how the combination of world-class scientific expertise, outstanding project management, and key regulatory insight can streamline our support for your therapeutic.

About the event 

The American Society of Gene & Cell Therapy is the primary professional membership organization for gene and cell therapy. The Society's members are scientists, physicians, patient advocates, and other professionals. Our members work in a wide range of settings including universities, hospitals, government agencies, foundations, and biotechnology and pharmaceutical companies.  

The mission of ASGCT is to advance knowledge, awareness, and education leading to the discovery and clinical application of genetic and cellular therapies to alleviate human disease. ASGCT's strategic vision is to be a catalyst for bringing together scientists, physicians, patient advocates, and other stakeholders to transform the practice of medicine by incorporating the use of genetic and cellular therapies to control and cure human disease.  And you can learn more on their website

New Orleans ASGCT 2025

Schedule a meeting with our experts on site

Learn how the combination of world-class scientific expertise, outstanding project management, and key regulatory insight can streamline our support for your therapeutic.